Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha lipoic acid for correction of PCOS complications in women undergoing ICSI
IRCT20191210045681N1Phase 3Completed
- Sponsor
- ACECR
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alpha-lipoic acid in polycystic ovary syndrome (PCOS), sponsored by ACECR. Started Jan 2020; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20191210045681N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191210045681N1.